Thin Gingiva

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Gingival Phenotype ModificationN/A1 trial
Active Trials
NCT05295771Withdrawn0Est. Jan 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Geistlich PharmaGingival Phenotype Modification

Clinical Trials (1)

NCT05295771Geistlich PharmaGingival Phenotype Modification

Evaluation of Geistlich Fibro-Gide ® and Autogenous Connective Tissue Graft Prior to Orthodontic Maxillary Expansion.

Start: Apr 2022Est. completion: Jan 20240
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space